WO2002012475A3 - C1q-related factor, homologous polypeptides and therapeutic uses thereof - Google Patents
C1q-related factor, homologous polypeptides and therapeutic uses thereof Download PDFInfo
- Publication number
- WO2002012475A3 WO2002012475A3 PCT/US2001/021109 US0121109W WO0212475A3 WO 2002012475 A3 WO2002012475 A3 WO 2002012475A3 US 0121109 W US0121109 W US 0121109W WO 0212475 A3 WO0212475 A3 WO 0212475A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- therapeutic uses
- homologous polypeptides
- related factor
- cerebellin
- similarity
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/472—Complement proteins, e.g. anaphylatoxin, C3a, C5a
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01958853A EP1328632A2 (en) | 2000-08-04 | 2001-07-23 | C1q-related factor, homologous polypeptides and therapeutic uses thereof |
AU2001280464A AU2001280464A1 (en) | 2000-08-04 | 2001-07-23 | C1q-related factor, homologous polypeptides and therapeutic uses thereof |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22323600P | 2000-08-04 | 2000-08-04 | |
US60/223,236 | 2000-08-04 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002012475A2 WO2002012475A2 (en) | 2002-02-14 |
WO2002012475A3 true WO2002012475A3 (en) | 2003-05-15 |
Family
ID=22835644
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/021109 WO2002012475A2 (en) | 2000-08-04 | 2001-07-23 | C1q-related factor, homologous polypeptides and therapeutic uses thereof |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1328632A2 (en) |
AU (1) | AU2001280464A1 (en) |
WO (1) | WO2002012475A2 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002216671A1 (en) * | 2000-11-29 | 2002-06-11 | Zymogenetics Inc. | Adipocyte complement related protein zacrp12 |
AU2014324884B2 (en) | 2013-09-25 | 2020-03-26 | Cytomx Therapeutics, Inc | Matrix metalloproteinase substrates and other cleavable moieties and methods of use thereof |
DK3628328T3 (en) | 2014-01-31 | 2022-12-05 | Cytomx Therapeutics Inc | MATRIPTASE AND U PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE PARTS AND METHODS OF USING THEREOF |
MA41374A (en) | 2015-01-20 | 2017-11-28 | Cytomx Therapeutics Inc | MATRIX METALLOPROTEASE CLIVABLE AND SERINE PROTEASE CLIVABLE SUBSTRATES AND METHODS OF USE THEREOF |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042576A1 (en) * | 1998-02-23 | 1999-08-26 | Smithkline Beecham Plc | Cerebellin-2 related polypeptides and dna coding therefor |
-
2001
- 2001-07-23 EP EP01958853A patent/EP1328632A2/en not_active Withdrawn
- 2001-07-23 AU AU2001280464A patent/AU2001280464A1/en not_active Abandoned
- 2001-07-23 WO PCT/US2001/021109 patent/WO2002012475A2/en not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999042576A1 (en) * | 1998-02-23 | 1999-08-26 | Smithkline Beecham Plc | Cerebellin-2 related polypeptides and dna coding therefor |
Non-Patent Citations (5)
Title |
---|
BERUBE NATHALIE G ET AL: "Cloning and characterization of CRF, a novel C1q-related factor, expressed in areas of the brain involved in motor function.", MOLECULAR BRAIN RESEARCH, vol. 63, no. 2, 8 January 1999 (1999-01-08), pages 233 - 240, XP002205214, ISSN: 0169-328X * |
DATABASE EMBL [online] EBI, Hinxton, UK; 14 December 1999 (1999-12-14), "Homo sapiens BAC clone RP11-17N4 from 2, complete sequence.", XP002205216, Database accession no. AC016673 * |
See also references of EP1328632A2 * |
URADE Y ET AL: "PRECEREBELLIN IS A CEREBELLUM-SPECIFIC PROTEIN WITH SIMILARITY TO THE GLOBULAR DOMAIN OF COMPLEMENT C1Q B CHAIN", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 88, no. 3, 1991, 1991, pages 1069 - 1073, XP002205215, ISSN: 0027-8424 * |
WADA C & OHTANI ET AL: "Molecular cloning of rat cerebellin-like protein cDNA which encodes a novel membrane-associated glycoprotein", MOLECULAR BRAIN RESEARCH, ELSEVIER SCIENCE BV, AMSTERDAM, NL, vol. 9, no. 1/2, January 1991 (1991-01-01), pages 71 - 77, XP002103511, ISSN: 0169-328X * |
Also Published As
Publication number | Publication date |
---|---|
EP1328632A2 (en) | 2003-07-23 |
WO2002012475A2 (en) | 2002-02-14 |
AU2001280464A1 (en) | 2002-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002014358A3 (en) | Novel secreted proteins and their uses | |
WO2002008277A3 (en) | Nucleic acids, vectors, host cells, polypeptides, and uses thereof | |
WO2001046420A3 (en) | Il-17 and il-17r homologous polypeptides and therapeutic uses thereof | |
WO2002032939A3 (en) | Secreted proteins and their uses | |
WO2002012475A3 (en) | C1q-related factor, homologous polypeptides and therapeutic uses thereof | |
WO2002026801A3 (en) | Secreted proteins and their uses | |
WO2001092493A3 (en) | 21956 and 25856, human aminopeptidases and uses thereof | |
WO2002048361A3 (en) | Novel secreted proteins and their uses | |
WO2002006330A3 (en) | 13237,18480,2245 or 16228 human protein kinase molecules and uses therefor | |
WO2002016578A3 (en) | Secreted proteins and methods of using same | |
WO2002000709A3 (en) | Cerebellin homologous polypeptides and therapeutic uses thereof | |
WO2002002771A3 (en) | Human sparc-homologous (hsparc-h1) gene and methods and uses thereof | |
WO2002046408A3 (en) | Human proteins, polynucleotides encoding them and methods of using the same | |
WO2003020912A3 (en) | Novel clark protein and nucleic acid molecules and uses therefor | |
WO2001090365A3 (en) | Human protein kinase '13305' and uses therefor | |
WO2002016579A3 (en) | Nucleic acids, vectors, host cells, polypeptides and uses thereof | |
WO2004013281A3 (en) | Novel proteins and their uses | |
EP1529843A3 (en) | Novel secreted proteins and their uses | |
WO2002016588A3 (en) | 15985, a human serine/threonine protein kinase family membe r and uses thereof | |
AU2002234132A1 (en) | 13245, a novel human myotonic dystrophy type protein kinase and uses therefor | |
WO2003035840A3 (en) | 69583 and 85924, novel human protein kinase family members and uses therefor | |
WO2002018439A3 (en) | 52991, a human transporter protein and uses therefor | |
WO2003029778A3 (en) | Novel secreted proteins and their uses | |
WO2004044126A3 (en) | Novel proteins and their uses | |
WO2003083048A3 (en) | Novel secreted proteins and their uses |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001958853 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001958853 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001958853 Country of ref document: EP |